To further explore whether GPC3-Syn-IL12-NK92 cells could increase the antitumor activities of GPC3-28Z CAR-T cells in vivo, a xenograft tumor was established with GPC3+ Huh-7 cells in NSG mice. This evidence concerns the gene GPC3 and neoplasm.